Don’t Miss : EOG Resources, Inc. (NYSE:EOG), Frontier Communications Corporation (NASDAQ:FTR), NanoString Technologies, Inc. (NASDAQ:NSTG), Verisk Analytics (NASDAQ:VRSK), Northern Tier Energy (NYSE:NTI)

EOG Resources (NYSE:EOG) was upgraded by research analysts at Sanford C. Bernstein from a “market perform” rating to an “outperform” rating in a report released on Monday, TheFlyOnTheWall.com reports. EOG Resources, Inc. (NYSE:EOG) belongs to Basic Materials sector. Its net profit margin is 15.50% and weekly performance is -10.44%. On last trading day company shares ended up $83.84. EOG Resources, Inc. (NYSE:EOG) distance from 50-day … Continue reading Don’t Miss : EOG Resources, Inc. (NYSE:EOG), Frontier Communications Corporation (NASDAQ:FTR), NanoString Technologies, Inc. (NASDAQ:NSTG), Verisk Analytics (NASDAQ:VRSK), Northern Tier Energy (NYSE:NTI)

Worth Watching Stocks : General Electric Company (NYSE:GE), Home Depot (NYSE:HD), Powell Industries (NASDAQ:POWL), Delcath (NASDAQ:DCTH), Verisk Analytics (NASDAQ:VRSK)

General Electric Company (NYSE:GE), which already has a formidable presence in Africa, said on Monday it was planning $US2 billion in new investments to build and assemble equipment for oil and other industries, as well as training in health and other sectors. General Electric Company (NYSE:GE) belongs to Industrial Goods sector. Its net profit margin is 8.80% and weekly performance is -1.25%. On last trading … Continue reading Worth Watching Stocks : General Electric Company (NYSE:GE), Home Depot (NYSE:HD), Powell Industries (NASDAQ:POWL), Delcath (NASDAQ:DCTH), Verisk Analytics (NASDAQ:VRSK)

Pre-Market Noise Makers: Northwest Biotherapeutics (NASDAQ:NWBO), Children’s Place (NASDAQ:PLCE), Cooper Companies (NYSE:COO), Verisk Analytics (NASDAQ:VRSK)

Shares in Northwest Biotherapeutics (NASDAQ:NWBO), a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, have jumped 12% pre-market after the company said the Data Safety Monitoring Board has recommended its Phase III trial into a lethal form of brain cancer continue. The company’s lead program is a 312-patient Phase III trial in newly diagnosed Glioblastoma multiforme (GBM). Northwest Biotherapeutics (NASDAQ:NWBO)’s stock on … Continue reading Pre-Market Noise Makers: Northwest Biotherapeutics (NASDAQ:NWBO), Children’s Place (NASDAQ:PLCE), Cooper Companies (NYSE:COO), Verisk Analytics (NASDAQ:VRSK)